Roche, Promega, University of Pittsburgh | GenomeWeb

Roche, Promega Litigation Heats Up With Fresh Salvo Alleging Overcharging Scheme

Promega last week sued Roche for allegedly overcharging the US government and its agencies by requiring royalty payments for research using the Taq DNA polymerase. In its response one day later, Roche called Promega’s suit an “overcharging scheme” and a “[simple] litigation tactic,” and said it lacks merit.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.